ASPI vs BAK

ASP Isotopes Inc. vs Braskem SA — Valuation Comparison 2026

ASPI

Chemicals
ASP Isotopes Inc.
Quality
5.8
out of 10
Value Trap
24
SAFE
Price
$7.77
Last close
Models
11/13
Active
VS

BAK

Chemicals
Braskem SA
Quality
5.5
out of 10
Value Trap
6
SAFE
Price
$4.46
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType ASPI Fair ValueASPI Upside BAK Fair ValueBAK Upside
Bayesian DCF Intrinsic $2.23 -71.3% $19.06 +327.4%
Earnings Power Value Intrinsic $0.06 -98.8%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $0.51 -90.1% $8.82 +97.7%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ASPI vs BAK — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ASPI vs BAK — Which Stock Is More Undervalued?

ASPI scores higher with a 5.8/10 quality rating vs BAK's 5.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ASP Isotopes Inc. (ASPI) and Braskem SA (BAK) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ASPI currently trades at $7.77 with a QOC of 5.8/10, while BAK trades at $4.46 with a QOC of 5.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).